RT
Red Tree Management, LLC
13F filer · CIK 0002055980Reported Jul 22, 2026
Net seller this quarter
13F portfolio value$147MU.S. long equity reported on 13F
Positions30 new · 0 closed
Net flow last quarter-$208KBuys minus sells
Top 10 positions weight100.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 22, 20263 positions | |||||
| BTBCAXBicara Therapeutics Inc. | $93.9M | 63.77% | 4.80% | -0.2% | Q4 2024 |
| $42.9M | 29.13% | 5.77% | Not reported | Q4 2024 | |
| $10.5M | 7.10% | 2.76% | Not reported | Q4 2024 | |
| Q1 2026Reported Apr 22, 20263 positions | |||||
| BTBCAXBicara Therapeutics Inc. | $63.1M | 56.39% | 4.84% | Not reported | Q4 2024 |
| $40.4M | 36.15% | 5.83% | Not reported | Q4 2024 | |
| $8.33M | 7.45% | 2.76% | Not reported | Q4 2024 | |
| Q4 2025Reported Feb 11, 20263 positions | |||||
| BTBCAXBicara Therapeutics Inc. | $53.4M | 48.94% | 5.60% | Not reported | Q4 2024 |
| $48.4M | 44.37% | 5.88% | Not reported | Q4 2024 | |
| $7.29M | 6.69% | 2.76% | Not reported | Q4 2024 | |
| Q3 2025Reported Nov 7, 20253 positions | |||||
| BTBCAXBicara Therapeutics Inc. | $50.1M | 60.39% | 5.81% | Not reported | Q4 2024 |
| $25.3M | 30.57% | 5.95% | Not reported | Q4 2024 | |
| $7.5M | 9.04% | 2.28% | Not reported | Q4 2024 | |
Premium opens every quarter this fund has filed